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ABSTRACT
Coal mine lung dust disease (CMDLD) and artificial
stone (AS) silicosis are preventable diseases which have
occurred in serious outbreaks in Australia recently. This
has prompted a TSANZ review of Australia’s approach to
respiratory periodic health surveillance. While regulat-
ing respirable dust exposure remains the foundation of
primary and secondary prevention, identification of
workers with early disease assists with control of further
exposure, and with the aims of preserving lung function
and decreasing respiratory morbidity in those affected.
Prompt detection of an abnormality also allows for
ongoing respiratory specialist clinical management. This
review outlines a medical framework for improvements
in respiratory surveillance to detect CMDLD and AS sili-
cosis in Australia. This includes appropriate referral,
improved data collection and interpretation, enhanced
surveillance, the establishment of a nationwide Occupa-
tional Lung Disease Registry and an independent advi-
sory group. These measures are designed to improve
health outcomes for workers in the coal mining, AS and
other dust-exposed and mining industries.
Key words: coal mine dust lung disease, pneumoconiosis,
prevention, respiratory surveillance, silicosis.
INTRODUCTION
The recent reappearance of coal workers’ pneumoconi-
osis (CWP)1,2 and emergence of artificial stone (AS)-
associated silicosis3–5 has represented a failure of pre-
ventive systems to protect the respiratory health of
workers in Australia. This resurgence of pneumoconio-
sis has occurred at a time when production has
increased, mining techniques have been further mech-
anized and responsibilities for medical care out-
sourced, despite state- and nation-specific regulations
to control respirable dust levels. In 2016, the Thoracic
Society of Australia and New Zealand (TSANZ)
highlighted key issues relating to the pressing need to
improve periodic health surveillance for coal mine
workers.6 Some but not all of these recommendations
have been implemented.
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This paper provides a framework for an optimal sur-
veillance system of these workers in Australia and
New Zealand and for improvements in the existing
respiratory surveillance programme (Box 1). We
emphasize that respiratory surveillance differs from
targeted case finding such as has been implemented
for AS workers in some states, and also from popula-
tion screening for non-occupational diseases (Box 2).7
Detection of coal mine dust lung diseases (CMDLD)
and AS silicosis at an early stage should facilitate more
effective management and allow avoidance of further
dust exposure to benefit individual workers. Our frame-
work is based on existing literature including the
review of the Queensland Coal Mine Worker’s Health
Scheme,8 WorkCover Queensland’s (WCQ) review of
stonemasons with silicosis,9 targeted literature searches
and international guidelines. It also includes opinion
from national and international experts in the field.
This framework could potentially be used in construc-
tion, crafts and related trades as well as other mining
operations which involve exposure to mineral dusts.
Although the outbreak of pneumoconiosis has to date
primarily affected Australia, this position paper has
been developed co-operatively and includes expertise
from both countries, being intended to apply to both
BOX 1. Goals and directions proposed
by the Thoracic Society of Australia and
New Zealand
Goals of this review
• To promote awareness among physicians and
healthcare professionals about artificial stone
(AS) silicosis and the spectrum of coal mine dust
lung disease (CMDLD), and provide the rationale
to support enhanced respiratory surveillance of
exposed workers in Australia and New Zealand.
• To highlight optimal surveillance strategies which
will identify workers at risk of CMDLD and AS-
associated silicosis at an early stage in order to
allow timely implementation of effective
interventions and advance personalized
management.
Proposed directions
• Improvements in collection of periodic health
surveillance data and its interpretation in
accordance with established practice and
international guidelines, emphasizing longitudinal
comparisons within individuals and enabling
these data to become available for research and
clinical decision-making.
• Enhanced surveillance methods to include diffusing
capacity measurements, computed tomography for
coal miners and AS workers where applicable at as
low dose as possible; increased frequency of
surveillance for symptomatic and high-risk groups,
and evaluation of these strategies within prospective
studies.
• Improved availability of cumulative dust exposure
measurements for supervising medical advisors at
the time of examining exposed workers, for
respiratory physicians after referral, and to enable
improved research into dose–response
relationships between exposure and disease.
• Diagnoses of CMDLD/AS silicosis to be confirmed
by occupational respiratory multidisciplinary
teams with the recording of all such diagnoses
within a centralized national registry as notifiable
conditions, facilitated by the establishment of a
central expert Occupational Lung Disease
Advisory Group.
BOX 2. Occupational definitions as
adapted from Wagner7
Respiratory surveillance
Respiratory surveillance is a component of public
health practice involving the periodic collection,
analysis and reporting of information in a
workplace for disease detection and prevention. In
contrast to population screening, respiratory
surveillance is directed towards improvement of
the health of workers who are exposed to a
known workplace respiratory risk factor.
Case-finding of an individual after a ‘sentinel event’
has occurred
Case-finding uses medical testing to make a
presumptive diagnosis of disease before an
individual would normally seek medical care,
usually when an available intervention can
favourably affect the person’s health. Case-finding
aims to detect disease in its ‘preclinical’ stage.
This allows monitoring of outbreaks and
subsequent secondary prevention of disease in
workplaces and communities.
Population screening
Screening is defined by the International Labour
Office (ILO) as ‘the presumptive identification of
unrecognized disease in an apparently healthy,
asymptomatic population by means of tests,
examinations or other procedures that can be
applied rapidly and easily to the target population.
A screening programme must include all the core
components in the screening process from
inviting the target population to accessing
effective treatment for individuals diagnosed with
disease’. Population screening is not the same as
respiratory surveillance.
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Australia and New Zealand. We aim to inform occupa-
tional physicians, general practitioners with special
training in occupational disease and respiratory surveil-
lance, and to provide a reference framework for respi-
ratory physicians who are referred such patients. We
also aim to benefit the workforce more broadly through
identifying workplaces and work practices that need
further hazard assessment.
This framework will expire 5 years from the date of
publication but will be discussed at future TSANZ
meetings as per TSANZ standard procedure for posi-
tion papers. Dust control is critical to disease preven-
tion but is outside the scope of this document. Specific
recommendations for dust control are available.10–13
POSITION STATEMENT
Clinical aspects of CMDLD
CMDLD comprise several diseases in addition to classi-
cal CWP,1,14,15 an interstitial lung disease resulting from
chronic inhalation of coal mine dust, otherwise known
as ‘black lung’. CWP is characterized by nodular, and
less commonly irregular opacities, on plain chest radio-
graphs.1 Most coalmine dust also contains a component
of respirable crystalline silica (RCS) which is more
fibrogenic than coal dust, potentially leading to silicosis
or mixed dust pneumoconiosis (MDP).16 The spectrum
of CMDLD, which includes chronic obstructive pulmo-
nary disease (COPD), is summarized in Table 1.15,17
Notably, diagnoses can be missed by medical surveil-
lance programmes that focus only on classical
radiographic-nodular CWP. The current clinical pathway
for CMDLD in Queensland is outlined in Figure 1,
where such respiratory surveillance has recently been
made mandatory with centralized reporting.
In individuals exposed to coal mine dusts, CWP
may develop into progressive massive fibrosis (PMF),
which may ultimately be fatal. PMF may also occur in
open cut or surface miners involved in drilling/
blasting without a prior history of underground
mining.18 Rapidly progressive pneumoconiosis (RPP)
is defined by the development of PMF and/or an
increase in small opacity profusion greater than one
International Labour Office (ILO) subcategory over
5 years.19,20 This is associated with respiratory failure,
right heart failure and premature death. RPP is associ-
ated with annual lung function declines of forced expi-
ratory volume in 1 s (FEV1) >60 mL/year compared
with miners without CWP,21 and occurs in CWP, sili-
cosis and MDP. There has been an alarming rise of
RPP/PMF diagnosed in the USA over the last
15 years,1,19,22,23; it is not yet clear whether this has
also occurred in our countries.
CMDLD also includes chronic bronchitis and
emphysema, which were documented in coal mine
workers in the 1940s.24 While initially attributed to
smoking alone, coal dust-related obstructive chronic
bronchitis (OCB), emphysema and accelerated lung
function decline have since been amply confirmed.25,26
These effects are additive rather than attributable to
smoking alone and can also occur without radiological
CWP on chest radiographs.25,27–29 Interstitial pulmo-
nary fibrosis related to coal mine dust exposure (dust-
related diffuse fibrosis or DDF) also occurs, and can be
identical clinically to other types of progressive
fibrosing interstitial lung disease.1
Clinical aspects of AS silicosis
AS silicosis, which progresses more rapidly than classi-
cal silicosis, is an emerging global public health issue
in workers in the kitchen/bathroom bench-top indus-
try.3,5 Cutting and grinding AS without dust controls
such as water suppression and local exhaust ventilation
(LEV) can generate very high levels of RCS and also
other substances potentially toxic to the lung. Unfortu-
nately, poor work practices have occurred in this
industry and periodic surveillance has been infre-
quently performed.
This progressive form of silicosis is not yet fully
understood. Disease may occur within 5 years of
exposure, with rapid lung function loss and radiologi-
cal progression.4 Symptoms may be delayed,
resulting in severe disease at first presentation.17 The
clinical features of AS silicosis include lung function
restriction, interstitial radiographic nodules and posi-
tive auto-antibodies, similar to those seen in classical
silicosis, and younger men are often affected.3,17
Shorter latency periods, rapid progression to PMF
and silico-proteinosis-like patterns on computed
tomography (CT) scanning and histopathology may
be found.
Lack of any effective treatment has added urgency to
primary prevention. Dust suppression, including a
combination of wet cutting methods and ventilatory




Caplan’s syndrome (rheumatoid pneumoconiosis)
Coal workers’ pneumoconiosis (CWP)
• Simple CWP
• Rapidly progressive pneumoconiosis





• Accelerated (e.g. artificial stone workers)
• Chronic (or classical)
COPD (with or without smoking)




Autoimmune disorders including MCTD, Sjögren’s
syndrome and others
Adapted from Perret et al.,15 with permission.
†Bronchoscopic and/or pathological diagnosis.
CMDLD, coal mine dust lung disease; COPD, chronic obstruc-
tive pulmonary disease; CWP, coal workers’ pneumoconiosis;
MCTD, mixed connective tissue disease.
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controls, can reduce RCS levels,30 but even wet cutting
of AS can produce levels that exceed the current work-
place exposure standard for Safe Work Australia’s time
weighted average (TWA) of 0.05 mg/m3, which is cur-
rently identical in New Zealand (NZ).11,13 (see also
http://hcis.safeworkaustralia.gov.au/
ExposureStandards/Details?exposureStandardID=1042).
Further controls need to be considered in relation to
the hierarchy of control, ordered from most to least
effective (i.e. product substitution, engineering
changes, administrative controls and then personal
protection equipment (PPE)), as captured in the
Australian and New Zealand Work Health and Safety
Legislation: clause 36 of the model Work Health and
Safety (WHS) for Australia11 and clause 6 of the NZ
Health and Safety at Work (general risk and workplace
management) Regulation.13
Use of PPE is the least effective control measure and
therefore should be regarded as the very last resort.
Periodic surveillance of workers to detect early disease
and optimal case management of diagnosed disease in
these young-to-middle-aged workers is critical.17 In a
recent retrospective review of 78 AS masons in Queens-
land who had been given a clinical diagnosis of silicosis
following active case finding and using high-resolution
CT (HRCT) scanning, 34 (43%) had normal plain chest
radiographs.9 Of these, at least two-thirds had spent
>50% of their total work tenure cutting and grinding
without appropriate dust controls. Some false-negative
findings occurred using chest radiographs alone, and
HRCT was a more sensitive diagnostic test.31 Although
these are early data,9 surveillance of workers with high
levels of exposure using low-dose CT (LDCT) is much
more likely to detect disease at an earlier stage com-
pared with plain radiographs, when removal from dust
exposure can assist long-term outcomes.
Improvements in lung function and imaging
techniques
Techniques for investigating occupational lung disor-
ders have improved significantly over recent decades
and should be incorporated into modern respiratory
surveillance methods. Improvements in lung function
testing, in predicted values for interpretation, and com-
puterized analysis of results should assist diagnosis.
Lung function testing beyond spirometry which
includes static lung volumes and diffusing capacity of
the lung for carbon monoxide (DLCO),32–34 should
enable detection of the full spectrum of CMDLD.
Although DLCO can be reduced by factors including
smoking,35,36 its ability to evaluate the gas exchange
surface is highly relevant for early detection of silicosis
and coal-related emphysema. Furthermore, the equip-
ment has become increasingly portable, so it can easily
be taken to the point of testing (e.g. remote mine sites).
Figure 1 Coal Mine Workers’ Health Scheme. This clinical pathway guideline documents the currently recommended process for
follow-up investigation and referral to appropriate medical specialists of workers with abnormal results. Additional information
supporting the guideline is available from https://www.dnrme.qld.gov.au/__data/assets/pdf_file/0005/1278563/cmwhs-clinical-path
ways-guideline.pdf. Adapted from Department of Natural Resources, Mines and Energy of the Queensland Government, with permis-
sion. FEV1, forced expiratory volume in 1 s; GLI, Global Lung Function Initiative; GP, general practitioner; HRCT, high-resolution
computed tomography; LLN, lower limit of normal; NMA, nominated or supervising medical practitioners; PA, postero-anterior.
© 2020 The Authors.
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Other developments include the derivation of interna-
tionally accepted reference values,37,38 novel software
to assist with monitoring rates of longitudinal lung
function decline39 and the option of secure, cloud-
based centralized data storage.
Importantly, more sensitive and specific radiological
techniques have been developed for the detection of
lung disease at an earlier stage. The diagnostic utility of
HRCT scans is superior to plain chest imaging in both
detecting and evaluating small parenchymal opacities
and in staging disease in CWP40–42 and silicosis. Applica-
tion of computerized software is increasingly allowing
quantification of extent of emphysema and interstitial
lung disease, as well as assessment of the airway com-
ponents of COPD. The use of LDCT with typical radia-
tion exposure of 1.5 mSv has also enabled early
detection of lung cancers and screening is rec-
ommended for those at increased risk in several coun-
tries.43,44 The ionizing radiation doses of ultralow-dose
CT (uLDCT) protocols now approaches that of plain
chest radiographs (0.12–0.20 vs 0.10 mSv),45,46 without
substantially losing diagnostic quality.45,47 This contrasts
with the estimated annual exposure for an average
Australian of 1.5 mSv from natural sources.48 However,
uLDCT has not yet been validated for the surveillance of
coal- and silica-related pneumoconioses.
CT scans should be interpreted by an experienced
thoracic radiologist with understanding of the Interna-
tional Classification of Occupational and Environmen-
tal Respiratory Diseases (ICOERD) system49 and
RANZCR recommendations.50 Ideally, the ICOERD sys-
tem should be updated and adopted internationally.
Radiological grading scales provide prognostic risk of
disease progression in individuals with advanced dis-
ease. For example, coal mine workers with ILO grade
>2/1 have an estimated 1 in 8 chance (12.5% risk) of
developing PMF within 5 years.51 At a population level,
such reporting in accordance with occupational imag-
ing classification standards can more accurately esti-
mate incidence, prevalence and severity of
occupationally acquired lung diseases.
There is a need to regularly monitor clinician compe-
tency in interpreting images, such as the ‘B’ reader course,
which has recently been introduced in Queensland,
although no such certification exists for CT scanning.
TSANZ’s course on occupational lung diseases provides
the opportunity for an annual update for clinicians, but
optimally this area requires further development.
The way forward: optimizing
respiratory periodic health
surveillance
Improving collection of exposure data (dust
sampling)
Exposure to respirable coal mine dust has been subject
to much research; however, this is not true for AS expo-
sure. Measurements of workplace RCS are needed to
understand cumulative exposures a worker may have
experienced but need to be analysed by an accredited
analytical facility. Dust monitoring should occur under
typical working conditions, not when work is performed
at less than usual capacity. Careful review of compliance
to national standards for RCS collection and analysis52 is
required. Ideally, individual exposure data should be
available at the time of surveillance, accessible via a cen-
tralized database. Although outside the scope of this
paper, improved national and international collabora-
tion is needed between occupational health staff, engi-
neers involved in dust control and treating doctors.
A detailed occupational exposure history is essential
for all workers including a full chronological history of
all jobs, use (or lack of) of appropriate dust controls in
current and previous employment and other exposures,
particularly concurrent smoking and vaping. Accurate
dust measurements suitable for pooled data analysis
are required to better inform policy on appropriate
respirable dust limits; this requires close collaboration
with occupational hygienists.
Improving health record documentation and
interpretation
The review of the coal miners’ periodic health surveil-
lance system in Queensland highlighted multiple areas
where improvements were needed.8 These included
poor performance and interpretation of spirometry,
and deficiencies in quality control and administrative
procedures. Chest radiograph interpretation was lim-
ited by suboptimal film quality, lack of clinical informa-
tion and lack of recognition of early disease. Surface
workers exposed to dust in open cut mines were not
routinely included in surveillance despite being at risk
of CMDLD.8 There was lack of a quality assurance pro-
gramme and of adherence to international standards.
The B reader programme using chest radiographs
which is used in the USA and is evidence based and
relies on regular clinician training53–55 was not in oper-
ation, and no quality control programme for clinician
competency was followed.
Our proposed improvements in periodic surveillance
programmes for the conduct and interpretation of test-
ing as well as other directions are shown in Table 2.
Illustrative references have been provided as a full dis-
cussion is beyond the scope of this paper.
For surveillance for CMDLD, we recommend that
the diagnostic utility of uLDCT needs to be compared
with that of the ILO classifications of plain chest radio-
graphs in prospective studies. While randomized con-
trolled trials would provide the best evidence for the
evaluation of comparative efficacy, such studies would
need to be performed over long periods, due to the
prolonged latency periods of these diseases.
When interpreting spirometry, a fixed cut-off value of
post-bronchodilator FEV1/forced vital capacity (FVC)
<0.70 has previously been recommended to define air-
ways obstruction.62 However, this under-diagnoses air-
flow obstruction for younger and taller working adults
up to their early 40s, and overestimates this in older,
shorter subjects. The internationally recognized Global
Lung Function Initiative (GLI) predicted values has
allowed better definition of the limits of normality,37,38
and should be adopted; multiple serial measurements
are needed for optimal accuracy.39
Databases used for health surveillance need to com-
pare serial lung function data over a working life. It is
highly desirable to link these databases with
Respirology (2020) 25, 1193–1202 © 2020 The Authors.
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occupational histories and occupational hygiene data,
enabling medical practitioners to be better informed
regarding type, duration and intensity of exposures.
Doctors assessing serial lung function data require
appropriate and ongoing training to identify lung func-
tion decline beyond that of age-related decline and
measurement variability, using longitudinal analysis
software such as SPIROLA.39 The SPIROLA software
also allows monitoring of the quality of spirometry for
the purposes of quality assurance which is also impor-
tant for medical surveillance.
Frequency of surveillance and individual
management
Most existing surveillance programmes in the mining
industries use a uniform system regardless of individ-
ual risks; however, the field is now moving beyond the
‘one-size-fits-all’ approach. Although workers who
have been consistently employed in roles associated
with higher dust exposures appear at greater risk of
developing lung disease, other factors may contribute
(e.g. genetic predisposition,15 concomitant smoking
and/or pre-existing respiratory diseases). One impor-
tant benefit from this ‘personalized’ approach could be
to facilitate a worker’s knowledge of potential adverse
effects from respirable dust exposures, provide smoking
cessation advice and encourage the reporting of new
respiratory symptoms that might represent early dis-
ease or disease progression.
The frequency with which respiratory surveillance is
performed in coal miners is not standardized within
Australia and New Zealand, but it usually occurs 3–5
yearly. International recommendations suggest more
frequent lung function testing to identify accelerated
lung function decline at an earlier stage.1,57 The
U.S. National Institute for Occupational Safety and
Health (NIOSH) programme consists of mandatory spi-
rometry/chest X-ray examination upon entry into min-
ing and after 3 years, then annual spirometry and chest
Table 2 Optimizing periodic health surveillance in the coal and AS industry
Proposed improvements to periodic health surveillance Citation/s
Regular training of staff in accordance with international standards including quality control and quality
assurance, including accurate interpretation of lung function data by supervising medical practitioners
8,32,33,39
Plain chest radiographs to be performed using ILO recommended techniques and to be technically
acceptable. Classification only by qualified thoracic radiologists, preferably with B-reader qualifications,
and compared with previous images
8,20
Individual spirometry results to be interpreted using reference values of the GLI, with serial data compared
with longitudinal predicted values, while adopting the lower limit of normal to define lung function
abnormality
8,37–39
Dust monitoring information under typical working conditions (≥75% capacity) and considered if
substantive changes are made to facility, processes and practices, to be recorded using an accredited
facility, with individualized data available at the time of periodic surveillance
3,10,11
Extending surveillance methods for AS exposure to potentially include LDCT, reported by expert thoracic
radiologists; careful evaluation of the role for uLDCT for coal miner and AS workers within longitudinal
prospective studies
9,56
Extending surveillance methods for all workers to include lung diffusing capacity according to ATS/ERS
standards at intervals of 3 years or less with careful evaluation of such surveillance within longitudinal
prospective studies
27,32,33,56
A flexible approach to the timing of surveillance of coal mine dust workers, including annual spirometry
and DLCO if results are abnormal but do not yet fulfil diagnostic criteria for disease
7,56,57
For AS workers previously exposed to high RCS levels, active case-finding using conventional HRCT/
spirometry/DLCO performed at accredited respiratory laboratories and radiological facilities using
recommended protocols; follow-up by expert treating specialists/teams, preferably at occupational
respiratory MDTs
9,32,33,50,58,59
For AS workers, pre-employment plain chest radiographs to exclude major abnormalities. For AS workers
undergoing active case-finding without abnormal CXR or HRCT, annual spirometry/DLCO and imaging
3-yearly or more often depending on individual factors and test results
17
Complementing surveillance CXR imaging with HRCT scans in high-risk groups, for example, where
borderline fibrosis is found on plain chest radiographs and/or where discrepancy exists with lung
function findings
49,60
Improving existing medical databases to allow capacity to compare serial lung function data, occupational
exposure history, imaging findings and dust measurements
39,61
Early review of the diagnostic utility of ‘best available tests’ (LDCT, uLDCT and DLCO) by comparisons with
plain chest radiographs and spirometry collected prospectively with consent from workers, ideally in a
research setting
AS, artificial stone; ATS/ERS, American Thoracic Society/European Respiratory Society; CXR, chest X-ray; DLCO, diffusing capacity
of the lung for carbon monoxide; GLI, Global Lung Function Initiative; HRCT, high-resolution computed tomography; ILO, International
Labour Office; LDCT, low-dose CT; MDT, multidisciplinary team; RCS, respirable crystalline silica; uLDCT, ultralow-dose CT.
© 2020 The Authors.
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X-ray examination every 2–5 years for both under-
ground and surface miners working in the industry
over their lifetime.7,56 Findings from mining regions
that exceed current respirable dust exposure limits sup-
port at least annual testing of spirometry, especially for
young smoking miners with bronchitis symptoms,26,63
but ideally spirometry should not be dependent on
dust measurements. Assessment of cross-sectional data
other than the baseline testing is generally not as useful
as serial measurements, especially if a worker begins
his/her career with above average readings. Whenever
possible, longitudinal patterns of lung function decline
should be estimated using the free SPIROLA soft-
ware.39,61 A web-based version of this software is due
for release soon (https://www.cdc.gov/niosh/topics/
spirometry/spirola-software.html).
Where radiological and physiological changes are
found but do not yet meet diagnostic criteria for clini-
cal disease, more frequent monitoring is indicated on
an individual basis, depending on the risk profile. For
example, a repeat chest X-ray in 2 years is suggested
for coal mine workers if there is radiological evidence
of category 1/0 or higher pneumoconiosis, and annual
spirometry if results are below the lower limit of
predicted normal and/or if there is accelerated FEV1
decline.56 Individuals with acute intense exposures
may warrant monitoring more frequently. It is impor-
tant that health surveillance continues after ceasing
employment because workers are still at risk in subse-
quent years,64,65 especially if a resignation was
prompted by health concerns.28 Specialist medical
evaluation is appropriate if there is uncertainty.
Implementing surveillance for AS workers
Given the exceptionally high exposure to RCS in the AS
industry in Australia, respiratory surveillance needs to
be considered separately from coal mine dust expo-
sure. Prior to the first Australian report of AS silicosis
cases,4 there was little workplace awareness of existing
regulations or the need for appropriate surveillance.
Subsequently, specific case finding programmes have
been implemented in some states to detect AS silicosis
in its ‘preclinical stage’ using conventional HRCT.50
Early results suggest that individual cases identified by
targeted screening may require frequent monitoring
with full lung function tests and CT, given the potential
for rapid progression of disease.4
The TSANZ supports optimal respiratory surveillance
methods in order to increase the detection of early dis-
ease. For individuals with significant exposure but no cur-
rent evidence of disease, there is consensus among
professional bodies including TSANZ, RANZCR, Royal
Australasian College of Physicians (RACP) and Austral-
asian Faculty of Occupational and Environmental Medi-
cine (AFOEM) that surveillance with LDCT is preferable
to plain chest radiography. Currently, it remains unclear
whether LDCT is non-inferior to HRCT. Similarly, annual
lung function testing and radiological surveillance at
intervals 3-yearly or less is preferred. Interval cases may
occur if the surveillance tests are spaced too far apart. For
workers new to the industry, it is not yet clear whether
LDCT is feasible as a baseline pre-employment test.
We acknowledge the lack of evidence regarding
enhanced radiological surveillance, and therefore sug-
gest further research. In the interim, RANZCR recom-
mendations should be followed. While we have
suggested it may be reasonable to initially adopt LDCT
given its use in lung cancer screening, it is essential
that future studies fully address the question of
whether the sensitivity of LDCT is sufficient to ade-
quately detect smaller and/or ground-glass nodules
that are characteristic of silicosis. A role for uLDCT in
occupational respiratory surveillance needs investiga-
tion if the use of LDCT becomes established. It is
important to recognize that improvements in dust con-
trol measures in this industry would be expected to
reduce the incidence of AS silicosis, but that lifelong
respiratory surveillance will still need to be conducted
due to the long latency between exposure and disease
development. Respiratory surveillance, as a secondary
screening tool, should be conducted regardless of how
well dust control measures improve, and should con-
tinue after the worker has left the employment and as
long as the worker agrees to this. Optimal respiratory
surveillance will ensure that new exposures or failures
in exposure controls are identified quickly and that
remediation occurs, while protecting workers’ respira-
tory health.
Formalizing clinical pathways to specialist
review
For equivocal and confirmed diagnoses identified by
case finding or periodic surveillance, early specialist
referral to an expert respiratory physician is rec-
ommended, while acknowledging potential difficulties
with accessibility and costs. These factors are
influenced by state, federal and healthcare systems.
Establishing links between employers, local, national
and international professional bodies can facilitate
these processes. As already demonstrated for lung can-
cer and idiopathic pulmonary fibrosis, diagnosis and
recommendations for clinical care are enhanced by a
specific multidisciplinary team (MDT) meeting that
enables consensus-based diagnosis and management.
Further investigation may require invasive procedures
such as bronchoscopy, endoscopic bronchial
ultrasound-guided or surgical lung biopsy. However, it
should be emphasized that these procedures are inva-
sive and should only be necessary in few cases. Opti-
mal management includes smoking cessation
interventions, psychological counselling and access to
supportive care such as pulmonary rehabilitation, vac-
cination and oxygen therapy where appropriate.1 Vigi-
lance is needed given the predisposition to
mycobacterial infection after silica exposure. Referral
for lung transplantation may be required.1 This multi-
disciplinary approach is likely to improve diagnostic
accuracy and improve workers’ health.
Establishing a centralized registry and
Occupational Lung Disease Advisory Group
Currently, information regarding the number and type
of cases of occupational lung diseases in Australia and
New Zealand is very poorly documented. The TSANZ,
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with the support of key medical professional bodies,
has proposed the establishment of a national registry
to record all cases of occupationally acquired lung dis-
ease. Formal registration of individuals with confirmed
occupationally related respiratory diagnoses within this
central registry would facilitate gathering of accurate
data and allow targeted interventions to protect other
workers. Diagnostic accuracy is paramount and should
be overseen by experts in occupational lung disease at
occupational lung MDT meetings (Occ-L-MDT). A sys-
tem of MDTs is already established in each Australian
state and in New Zealand for lung cancer and intersti-
tial lung diseases, and could easily be implemented
more widely. The formation of a national advisory
group (potentially also to include New Zealand) con-
sisting of expert practitioners in occupational and
respiratory medicine, occupational hygiene, radiology
and respiratory physiology could provide expert and
timely advice to practitioners and governments. Sys-
tems for notification of occupational lung diseases are
already being reviewed at state and national levels in
Australia and New Zealand. The recording of radiologi-
cal images, lung function measurements and dust
exposure data from industry and/or state mine regula-
tory authorities within a central registry would allow
analysis of disease features and monitoring of epidemi-
ological trends nationally.
CONCLUSIONS
The recent resurgence of CMDLD and the rapid emer-
gence of AS-associated silicosis in Australia have
highlighted a failure of enforcement of current regula-
tions for dust control as well as poor periodic respira-
tory surveillance. Given these past deficiencies, the
TSANZ now provides a framework to enhance existing
programmes and comply with international standards.
These includes the conduct, interpretation and audit of
respiratory surveillance testing, improvements in data-
base systems, a flexible approach to enhance individual
surveillance and expansion of surveillance testing to
include lung diffusing capacity and CT scanning.
TSANZ also recognizes the need to establish a firm evi-
dence base for enhanced surveillance by performing
appropriate research. Furthermore, TSANZ proposes
the establishment of a national registry for occupation-
ally acquired lung diseases and an independent Occu-
pational Lung Disease Advisory Group. This would
facilitate the continued improvement in existing
programmes, reduce preventable respiratory disease
and promote a positive and supportive workplace cul-
ture for Australian and New Zealand workers.
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